PLUS1
6.84
-0.36 (-5.0%)
-0.36 (-5.0%)
Upgrade to Real-Time
Afterhours (Closed)
Low
2.56
High
21.26
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sorrento Therapeutics Inc | SRNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.36 | -5.0% | 6.84 | 19:56:21 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.19 | 6.76 | 7.21 | 6.775 | 7.20 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 6.82 | 6.85 | 0.03 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 25,473 | 5,805,725 | $ 6.98 | $ 40,519,931 | 7,661,293 | 2.56 - 21.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:54 | 50 | $ 6.84 | USD |
Sorrento Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.95B | 285.66M | 281.12M | $ 39.99M | $ - | -1.30 | -5.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 156.97k | 37.20% |
Sorrento Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.39 | 8.44 | 6.76 | 7.32 | 5,957,083 | -1.55 | -18.47% |
| 1 Month | 7.44 | 9.07 | 6.76 | 7.71 | 7,544,531 | -0.60 | -8.06% |
| 3 Months | 14.50 | 14.51 | 6.76 | 9.36 | 9,590,646 | -7.66 | -52.83% |
| 6 Months | 5.8103 | 17.25 | 5.17 | 9.85 | 14,373,620 | 1.03 | 17.72% |
| 1 Year | 2.71 | 21.26 | 2.56 | 9.06 | 26,527,392 | 4.13 | 152.4% |
| 3 Years | 7.55 | 21.26 | 1.39 | 8.03 | 10,825,272 | -0.71 | -9.4% |
| 5 Years | 6.30 | 21.26 | 1.39 | 7.84 | 6,950,293 | 0.54 | 8.57% |
Sorrento Therapeutics Description
| Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates. |
